Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Titration of Subcutaneous Remodulin in PAH
NCT02847260Phase 4Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Apr 2012
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Apr 2012; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02847260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847260.